|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Gastrointestinal Neoplasm | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Digestive System Neoplasms | |||||
| Gastrointestinal Neoplasms | |||||
| Gastrointestinal Stromal Tumors | |||||
| 3 | More general conditions related to this trial | ||||
| Digestive System Diseases | |||||
| Gastrointestinal Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| 4 | Interventions listed in this trial | ||||
| SU011248 | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Sunitinib | |||||
| 6 | More general drug interventions related to this trial | ||||
| Angiogenesis Inhibitors | |||||
| Angiogenesis Modulating Agents | |||||
| Antineoplastic Agents | |||||
| Growth Inhibitors | |||||
| Growth Substances | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Pfizer | |||||